Reports have characterized IL-1β activation in response to Aβ [38, 61, 67], but our study evaluated the role of CASP11 for the first time as a new molecular player in the highly complex multi-protein process required for IL-1β activation and release in AD. This evidence concerns the gene SCAF11 and Alzheimer disease.